An Introduction to Reproductive Endocrinology
Reproductive endocrinology concerns the hormones and control mechanisms that regulate sexual development, function and reproduction. Fertility problems are common issues encountered, which affect about 15% of couples. While outcomes have improved for assisted reproduction, success rates remain low. Advances in epigenomics, genomics, transcriptomics, proteomics and metabolomics are facilitating IVF procedures and identifying oocytes with anomalies, resulting in a higher rate of live births. Molecular biomarkers of fertility problems have also been discovered. New formulations and delivery systems for GnRH analogues, gonadotropins, and sex steroids are further improving fertility outcomes. In terms of menopausal hormone replacement therapy, individualization, dose minimization, and early initiation of therapy, have increased the benefit-risk ratio.
Browse our gallery of video highlights and short articles from the conference hub, providing the latest expert insights from major conferences and peer-reviewed articles from the journal portfolio.
Our supporting partners do not constitute an endorsement of the content on this page.
Reproductive Endocrinology Content
Fezolinetant: A Potential Treatment for Moderate to Severe Vasomotor Symptoms of Menopause
touchREVIEWS in Endocrinology. 2023;19(2):69-72
During more than 30 years of clinical practice as a gynaecologist, I have observed that very few novel medications have had a significant impact in the field of women’s health. There have been additions to selective oestrogen receptor modulators (SERMs), variations of hormone therapies (HTs), contraceptives and more. However, nearly all of these are modifications of […]
Polycystic Ovary Syndrome as Metabolic Disease: New Insights on Insulin Resistance
touchREVIEWS in Endocrinology. 2023;19(1):71-7 DOI: https://doi.org/10.17925/EE.2023.19.1.71
Polycystic ovary syndrome (PCOS) is a very common disease, with an incidence of 5−21% in women during their fertile life (18–45 years of age) worldwide.1 PCOS is clinically diagnosed when two of the three 2003 Rotterdam consensus criteria are met: (i) chronic anovulation disorder (in the form of oligo- or anovulation up to amenorrhoea); (ii) clinical (e.g. […]
Scanning the horizon of pharmacological treatments for women experiencing vasomotor symptoms during menopause: What’s new in 2022?
Watch this two-part activity exploring the latest data on pharmacological treatments for vasomotor symptoms (VMS) associated with menopause. Filmed following the 2022 North American Menopause Society (NAMS) Annual Meeting and the International Menopause Society (IMS) 18th World Congress on Menopause. Part 1: Watch menopause expert Prof. Steven Goldstein review key data from the 2022 NAMS Annual Meeting and the IMS 18th World Congress on Menopause Watch Now Part 2: Choose from leading menopause experts who discuss what these data may mean for clinical practice in the USA Select An Interview
- Describe the benefits and risks of hormone therapy for vasomotor symptoms associated with menopause
- Outline the rationale for non-hormonal therapy and mechanisms of action of emerging options for the treatment of vasomotor symptoms associated with menopause
- Recall the latest data for emerging non-hormonal therapies for the treatment of vasomotor symptoms associated with menopause
Nicholas Panay, World Menopause Day: Symptoms, treatment options and the importance of bone health
Here at Touch Medical Media we are supporting World Menopause Day (18th October 2022), an important initiative from the International Menopause Society to raise awareness of the menopause and improve health and wellbeing. We were delighted to speak with Mr Nicholas Panay (Imperial College, Queen Charlotte’s and Chelsea & Westminster Hospitals, London, UK), who talks […]
World Menopause Day 2021: Sharing experiences of navigating the perimenopause and menopause
As part of our campaign around World Menopause Day, an important initiative from the International Menopause Society to raise awareness of the menopause and the support options available for improving health and wellbeing. Here at Touch Medical Media we pride ourselves on a supportive working culture and have been looking at ways to support members […]
World Menopause Day 2021: Perspectives on managing symptoms
Here at Touch Medical Media we have been working to build an awareness and understanding of the menopause across our organisation, as well as to improve the support available for those experiencing menopause in the workplace. As such, we are delighted to support this year’s World Menopause Day, an initiative from the International Menopause Society […]
Contemporary Non-hormonal Therapies for the Management of Vasomotor Symptoms Associated with Menopause: A Literature Review
touchREVIEWS in Endocrinology. 2021; 17(2):133–7 DOI: https://doi.org/10.17925/EE.2021.17.2.133
Nearly 75% of all menopausal women experience bothersome vasomotor symptoms, including hot flushes and night sweats.1 Declining levels of estrogen during menopause lead to a narrowing of the central thermal regulatory neutral tone. Minute changes in core body temperature, as little as 0.8 ± 0.99°C, can often trigger sweating and flushing in both perimenopausal and postmenopausal […]
Haitham Hamoda: An Update from the British Menopause Society
touchENDOCRINOLOGY joins Haitham Hamoda (King’s College Hospital, London, UK), Chairman of the British Menopause Society, to discuss the importance of raising awareness of issues relating to women’s health, and the aims and objectives of the British Menopause Society. Questions 1. What are the current unmet needs in the field of menopause and women’s health? (00:20-01:40) […]
Haitham Hamoda, World Menopause Day: Maintaining Bone Health and the Benefits and Risks of Hormone Replacement Therapy
touchENDOCRINOLOGY joins Haitham Hamoda (King’s College Hospital, London, UK), Chairman of the British Menopause Society, to discuss the need for World Menopause Day and its role in raising awareness, the impact of the menopause on bone health and the benefits and risks of hormone replacement therapy. Questions 1. How has World Menopause Day helped identify […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!